Who’s to blame for drug shortages

When someone tries to do good, it seems like someone else will find a way to downgrade it, or simply find blame where none resides. The Group Purchasing Organizations (GPOs) fight to keep drug shortages diminished – however, those in the medical device community, particularly Phil Zweig, Executive Director of Physicians Against Drug Shortages (PADS), wants the GPOs to take full responsibility for the deficiency.

As for the PADS, this group has no background or understanding of the supply chain management.

Mr. Zweig has taken it upon himself to run down the respectable name of the GPO, going so far as to hold this organization blameworthy for the acceleration of the AIDS virus, not to mention the untimely demise of two U.S. attorneys. Besides this, he included two sitting U.S. Senators as conspirators in concealing extensive corruption.

According to the HSCA, the U.S. Government Accountability Office (GAO), Department of Justice, Federal Trade Commission, the U.S. Supreme Court, the 8th Circuit Court of Appeals, academia, and virtually all of America’s 7,700 hospitals conducted a thorough investigation of GPO cost savings, administrative structure, and business practices.

The HSCA goes on to mention that such organizations as the FDA, HHS, GAO, and others have discovered through investigation that the issue of drug shortages falls into the hands of the drug manufacturers who had manufacturing problems, quality control issues, and barriers to getting new suppliers online.

For some reason, it appears that Mr. Zweig not only wants academia to discover negative conclusions about the GPO but also wants academia to suffer disciplinary action by their universities.

Even though the GPO has gained naysayers, this organization is working cooperatively with hospitals, manufacturers, distributors, and others to make hospitals and their patients feel secure in receiving vital and necessary drugs.